
News|Articles|February 1, 2002
- Pharmaceutical Technology-02-02-2002
- Volume 26
- Issue 2
Microbial Bioburden on Oral Solid Dosage Forms
Author(s)José E. Martinez
Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.
Advertisement
Articles in this issue
over 24 years ago
Using Earned-Value Analysis to Better Manage Projectsover 24 years ago
Modernizing Pharmaceutical Manufacturingover 24 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—August 14, 2026
2
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
3
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
4
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
5



